Prestige Consumer Healthcare Inc. (PBH) Financials

PBH Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 3.5 billion 1.7 billion
Dec. 31, 2025 3.5 billion 1.7 billion
Sept. 30, 2025 3.4 billion 1.6 billion
June 30, 2025 3.4 billion 1.6 billion

PBH Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 45.4 million 2.6 million
Dec. 31, 2025 75.3 million 2.7 million
Sept. 30, 2025 55.4 million 1.8 million
June 30, 2025 78.2 million 3.7 million

PBH Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 53.9 million
Dec. 31, 2025 46.7 million
Sept. 30, 2025 42.2 million
June 30, 2025 47.5 million

PBH Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 63.9 million 994.0 million 38.9 million
Dec. 31, 2025 62.4 million 1.0 billion 45.7 million
Sept. 30, 2025 119.1 million 993.1 million 47.9 million
June 30, 2025 139.5 million 992.7 million 50.0 million

PBH Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 47.7 million
Dec. 31, 2025 48.1 million
Sept. 30, 2025 49.3 million
June 30, 2025 49.8 million

PBH Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 5.2 million - 65.4 million 35.1 million
Dec. 31, 2025 3.0 million - 69.7 million 40.1 million
Sept. 30, 2025 2.1 million - 66.7 million 38.7 million
June 30, 2025 838000 - 63.4 million 34.9 million

PBH Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 281.6 million 140.8 million
Dec. 31, 2025 283.4 million 126.1 million
Sept. 30, 2025 274.1 million 120.0 million
June 30, 2025 249.5 million 114.4 million

PBH Revenue by Segment

Graph available only for paid members. Upgrade to see it.

PBH

Price: $49.02

52 week price:
42.62
80.30

Payout Ratio Range:
79.84%
517.23%

Earnings Per Share: 3.91 USD

P/E Ratio: 11.88

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 211300

Ebitda: 92.0 million

Market Capitalization: 2.3 billion

Links: